COMPLETE ABFM IN-TRAINING
EXAMINATION PREP PREMIUM
MCQS QUESTION BANK
This premium board review bank delivers clear clinical
scenarios, correct choices, and comprehensive
pathophysiological rationales designed to ensure success on the
ABFM In-Training Examination (ITE). Every question mirrors
the breakdown of core clinical competencies found on the formal
family medicine board exams, making it an essential tool for
residential tracking and self-assessment. Master high-yield
diagnostic criteria, guideline changes, and pharmacological
interventions using this structured, self-paced preparatory guide.
Part 1: Adult & Internal Medicine
Question 1
A 62-year-old male with a history of heart failure with
reduced ejection fraction (LVEF 30%) presents for a
routine follow-up. He is currently taking lisinopril,
carvedilol, and furosemide. His blood pressure is
118/74 mmHg and heart rate is 64 bpm. Laboratory
results show a potassium level of 4.1 mEq/L and an
eGFR of 52 mL/min/1.73m². Which of the following
medications should be added next to optimize his
guideline-directed medical therapy (GDMT)?
A. Amlodipine
B. Digoxin
,C. Spironolactone
D. Isosorbide dinitrate
Answer: C
Rationale: Spironolactone, a mineralocorticoid
receptor antagonist (MRA), is a foundational
pillar of HFrEF management. It has been shown
to significantly reduce mortality and
hospitalizations in patients with NYHA Class II-IV
heart failure who have an LVEF ≤ 35%, provided
their potassium is < 5.0 mEq/L and eGFR is > 30
mL/min/1.73m².
Question 2
A 45-year-old female presents with a 3-month
history of symmetric joint pain and morning stiffness
lasting over an hour in her bilateral wrists and
metacarpophalangeal (MCP) joints. Physical exam
reveals soft-tissue swelling and tenderness in the
affected joints. Rheumatoid factor (RF) and anti-
cyclic citrullinated peptide (anti-CCP) antibodies are
strongly positive. After confirming the diagnosis,
which of the following is the most appropriate initial
disease-modifying antirheumatic drug (DMARD) to
prescribe?
A. Prednisone monotherapy
B. Methotrexate
,C. Adalimumab
D. Ibuprofen scheduled daily
Answer: B
Rationale: Methotrexate is the gold-standard,
first-line conventional synthetic DMARD for
rheumatoid arthritis. It should be initiated early
to slow disease progression and prevent
irreversible joint destruction. NSAIDs and
glucocorticoids are used only as short-term
bridging therapies for symptomatic relief.
Question 3
A 58-year-old male with a history of type 2 diabetes
and chronic kidney disease (eGFR 42
mL/min/1.73m²) presents for a routine evaluation.
His hemoglobin A1c is 7.6% on maximal metformin
therapy. Urinalysis demonstrates persistent
albuminuria with a random urine albumin-to-
creatinine ratio of 210 mg/g. Which of the following
glucose-lowering agents provides the greatest
secondary benefit in slowing the progression of his
chronic kidney disease?
A. Glipizide
B. Sitagliptin
C. Empagliflozin
D. Pioglitazone
, Answer: C
Rationale: SGLT2 inhibitors, such as
empagliflozin or dapagliflozin, offer profound
independent cardiorenal protective benefits.
They are strongly recommended in patients with
type 2 diabetes and chronic kidney disease with
albuminuria to delay the progression of kidney
failure and reduce cardiovascular events.
Question 4
A 34-year-old female presents with acute onset of
painful, unilateral vision loss in her left eye over the
past 24 hours. She also notes that colors appear
washed out and experiences pain with eye
movements. On examination, a relative afferent
pupillary defect (RAPD) is present in the left eye.
What is the most appropriate next step in the
diagnostic evaluation?
A. Urgent intraocular pressure measurement
B. Non-contrast CT scan of the orbits
C. Magnetic resonance imaging (MRI) of the brain
and orbits with gadolinium
D. Reassurance and follow-up in 2 weeks
Answer: C
Rationale: The clinical picture is classic for acute
optic neuritis, which is highly associated with
EXAMINATION PREP PREMIUM
MCQS QUESTION BANK
This premium board review bank delivers clear clinical
scenarios, correct choices, and comprehensive
pathophysiological rationales designed to ensure success on the
ABFM In-Training Examination (ITE). Every question mirrors
the breakdown of core clinical competencies found on the formal
family medicine board exams, making it an essential tool for
residential tracking and self-assessment. Master high-yield
diagnostic criteria, guideline changes, and pharmacological
interventions using this structured, self-paced preparatory guide.
Part 1: Adult & Internal Medicine
Question 1
A 62-year-old male with a history of heart failure with
reduced ejection fraction (LVEF 30%) presents for a
routine follow-up. He is currently taking lisinopril,
carvedilol, and furosemide. His blood pressure is
118/74 mmHg and heart rate is 64 bpm. Laboratory
results show a potassium level of 4.1 mEq/L and an
eGFR of 52 mL/min/1.73m². Which of the following
medications should be added next to optimize his
guideline-directed medical therapy (GDMT)?
A. Amlodipine
B. Digoxin
,C. Spironolactone
D. Isosorbide dinitrate
Answer: C
Rationale: Spironolactone, a mineralocorticoid
receptor antagonist (MRA), is a foundational
pillar of HFrEF management. It has been shown
to significantly reduce mortality and
hospitalizations in patients with NYHA Class II-IV
heart failure who have an LVEF ≤ 35%, provided
their potassium is < 5.0 mEq/L and eGFR is > 30
mL/min/1.73m².
Question 2
A 45-year-old female presents with a 3-month
history of symmetric joint pain and morning stiffness
lasting over an hour in her bilateral wrists and
metacarpophalangeal (MCP) joints. Physical exam
reveals soft-tissue swelling and tenderness in the
affected joints. Rheumatoid factor (RF) and anti-
cyclic citrullinated peptide (anti-CCP) antibodies are
strongly positive. After confirming the diagnosis,
which of the following is the most appropriate initial
disease-modifying antirheumatic drug (DMARD) to
prescribe?
A. Prednisone monotherapy
B. Methotrexate
,C. Adalimumab
D. Ibuprofen scheduled daily
Answer: B
Rationale: Methotrexate is the gold-standard,
first-line conventional synthetic DMARD for
rheumatoid arthritis. It should be initiated early
to slow disease progression and prevent
irreversible joint destruction. NSAIDs and
glucocorticoids are used only as short-term
bridging therapies for symptomatic relief.
Question 3
A 58-year-old male with a history of type 2 diabetes
and chronic kidney disease (eGFR 42
mL/min/1.73m²) presents for a routine evaluation.
His hemoglobin A1c is 7.6% on maximal metformin
therapy. Urinalysis demonstrates persistent
albuminuria with a random urine albumin-to-
creatinine ratio of 210 mg/g. Which of the following
glucose-lowering agents provides the greatest
secondary benefit in slowing the progression of his
chronic kidney disease?
A. Glipizide
B. Sitagliptin
C. Empagliflozin
D. Pioglitazone
, Answer: C
Rationale: SGLT2 inhibitors, such as
empagliflozin or dapagliflozin, offer profound
independent cardiorenal protective benefits.
They are strongly recommended in patients with
type 2 diabetes and chronic kidney disease with
albuminuria to delay the progression of kidney
failure and reduce cardiovascular events.
Question 4
A 34-year-old female presents with acute onset of
painful, unilateral vision loss in her left eye over the
past 24 hours. She also notes that colors appear
washed out and experiences pain with eye
movements. On examination, a relative afferent
pupillary defect (RAPD) is present in the left eye.
What is the most appropriate next step in the
diagnostic evaluation?
A. Urgent intraocular pressure measurement
B. Non-contrast CT scan of the orbits
C. Magnetic resonance imaging (MRI) of the brain
and orbits with gadolinium
D. Reassurance and follow-up in 2 weeks
Answer: C
Rationale: The clinical picture is classic for acute
optic neuritis, which is highly associated with
